FdaApplication
NDA 207026
Identifiers
- fda_app_no: NDA207026
Properties
| Property | Value |
|---|---|
| applicant_name | VANTIVE US HEALTHCARE LLC |
| application_type | NDA |
| approval_date | 2015-01-13 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER | CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE | N/A/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;6.95GM/1000ML;0.187GM/1000ML (5000ML) | INJECTABLE;INJECTION |
| PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER | CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE | 3.68GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.34GM/1000ML;0.187GM/1000ML (5000ML) | INJECTABLE;INJECTION |
2 products